CL, US1845021021

Colgate-Palmolive Co stock (US1845021021): valuation focus after DCF-based overvaluation signal

29.05.2026 - 12:31:16 | ad-hoc-news.de

Colgate-Palmolive Co shares on the NYSE traded around the low 90 USD range after a fresh discounted cash flow analysis highlighted a sizable gap between intrinsic value estimates and the current stock price, keeping valuation in focus for the US consumer staples group.

CL, US1845021021
CL, US1845021021

Colgate-Palmolive Co shares on the New York Stock Exchange changed hands at about USD 91 in the latest session, leaving the US consumer staples stock near the upper end of its 12-month range as investors digested a new discounted cash flow valuation published on 05/28/2026 that points to a marked disconnect between intrinsic value estimates and the current market price, according to GuruFocus as of 05/28/2026.

The stock, which is part of the US large-cap consumer products universe, ended trading on 05/28/2026 at USD 91.29 on the NYSE, while after-hours quotes showed a modest dip to USD 91.43 in early extended trading, with MarketBeat data as of 05/28/2026 also indicating a year-to-date gain of roughly 17 percent for Colgate-Palmolive Co.

For investors following US blue chips, the fresh valuation work provides a timely data point ahead of the next earnings update and keeps the focus on how a highly rated household products name is priced relative to fundamental cash flow assumptions in the United States consumer staples sector.

The GuruFocus analysis dated 05/28/2026 calculates an earnings-based DCF intrinsic value of USD 37.09 per share and a free cash flow-based DCF intrinsic value of USD 53.76 per share for Colgate-Palmolive Co, implying that the stock price of USD 91.29 carries a negative margin of safety versus both models.

According to the same report on 05/28/2026, the earnings-driven model corresponds to a margin of safety of about -110.9 percent, while the FCF-based approach translates to a margin of safety of roughly -69.8 percent, leading the authors to characterize the stock as overvalued on a DCF and GF Value basis as of late May 2026.

The GuruFocus note also highlights that Colgate-Palmolive Co has delivered a year-to-date share price increase of 17.0 percent as of 05/28/2026, a performance that outpaced many defensive peers and helps explain why cash flow-based valuation models now screen as stretched versus longer term intrinsic value markers.

From a home-country perspective, Colgate-Palmolive Co remains firmly anchored in the United States, with its primary listing on the New York Stock Exchange under the ticker CL and regulatory filings made with the US Securities and Exchange Commission, which is the key information channel for domestic investors in US consumer staples companies.

In the German market, Colgate-Palmolive Co can be accessed via secondary listings such as Tradegate in euros, where the stock generally tracks the NYSE quote converted into EUR, giving retail investors in Germany an additional venue to follow the US household products name in their local currency, although liquidity is typically lower than on the US home exchange.

The discounted cash flow analysis does not alter Colgate-Palmolive Co's operating outlook but shifts the short-term narrative toward how much investors are currently willing to pay for the company's cash generation in home and personal care categories, particularly given its reputation as a defensive holding within the broader S&P 500 consumer staples cohort.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

  • Name: CL
  • Sector/industry: Consumer staples - household and personal care products
  • Headquarters/country: New York, United States
  • Core markets: North America, Latin America, Europe, Asia-Pacific
  • Key revenue drivers: Oral care, personal care, home care and pet nutrition brands
  • Home exchange/listing venue: New York Stock Exchange (CL)
  • Trading currency: USD

Colgate-Palmolive Co: core business model

Colgate-Palmolive Co focuses on branded oral care, personal care, home cleaning and pet nutrition products that are distributed globally, with revenues driven primarily by the strength of its toothpaste, toothbrush, soap, detergent and pet food franchises across both developed and emerging markets.

Valuation metrics and multiples for Colgate-Palmolive Co

The DCF-based assessment published by GuruFocus on 05/28/2026 offers a detailed snapshot of how Colgate-Palmolive Co screens on several valuation approaches relative to its current NYSE share price.

In that analysis, the earnings-based discounted cash flow model yields an intrinsic value of USD 37.09 per share when applying projected earnings and a required rate of return, which stands well below the observed market price of USD 91.29 on 05/28/2026 on the New York Stock Exchange, implying a significant valuation premium.

The free cash flow-based discounted cash flow model, which uses Colgate-Palmolive Co's historical and expected free cash flow data, sets intrinsic value at USD 53.76 per share as of 05/28/2026, still around 40 percent below the late May trading price, and leads the report to flag a margin of safety of -69.8 percent on this metric.

Beyond standalone DCF metrics, the same GuruFocus piece references the proprietary GF Value measure, which blends historical valuation multiples, an adjustment factor and Morningstar-style estimates, and concludes that on this composite yardstick the stock appears overvalued compared with fair value estimates as of 05/28/2026.

The report notes that the year-to-date gain of 17.0 percent for Colgate-Palmolive Co as of 05/28/2026 has expanded traditional valuation ratios such as price-to-earnings and price-to-free-cash-flow, though exact multiples are not specified in the summary, and argues that the recent price move has outpaced the rates justified by the fundamental cash flow forecasts embedded in the DCF work.

For comparison, MarketBeat data as of 05/28/2026 indicate that Colgate-Palmolive Co's closing price of USD 91.69 is situated near recent highs, which often results in elevated trailing P/E ratios for staples names when earnings progression is steady but not dramatically accelerating, although segment-level valuation figures are not directly provided.

Within this context, valuation-oriented investors may scrutinize not only DCF-derived intrinsic values but also how Colgate-Palmolive Co trades versus sector averages on traditional multiples, taking into account that high-quality consumer staples companies can maintain premiums for extended periods due to strong brands and resilient cash flows.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Sentiment and reactions on Colgate-Palmolive Co

The fresh discounted cash flow valuation and the stock's position near recent highs have sparked active debate on social platforms, where market participants discuss whether the premium multiples for this US consumer staples name are sustainable.

YouTubeXTikTokInstagram

Conclusion

The latest trading in Colgate-Palmolive Co on the New York Stock Exchange leaves the US household products group priced near recent highs at around USD 91, at the same time that an external discounted cash flow analysis dated 05/28/2026 estimates intrinsic value well below the current share price.

The valuation-focused module shows that both earnings-based and free cash flow-based DCF models from GuruFocus point to negative margins of safety for Colgate-Palmolive Co as of 05/28/2026, underlining a tension between market enthusiasm and model-derived fair value for this consumer staples name.

Looking ahead, how the stock trades will likely depend on whether upcoming quarterly results, cash flow trends and potential capital allocation decisions are strong enough to support the present premium multiples highlighted by the DCF work, or whether the share price gradually converges toward intrinsic value estimates in the eyes of valuation-sensitive investors.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.

So schätzen die Börsenprofis CL Aktien ein!

<b>So schätzen die Börsenprofis CL Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US1845021021 | CL | boerse | 69440654 | bgmi